Table 3.
Information about most relevant studies about Chagas disease prevalence among solid organ–transplanted population coming from endemic areas
| Reference and year of publication | Thambo, 198918 | Riarte, 19997 | Boin, 201019 | Fitzpatrick, 201020 | Rodríguez-Romo, 201321 | Salvador, 2018 |
|---|---|---|---|---|---|---|
| Country | Chile | Argentina | Brazil | United States | Mexico | Spain |
| Study period | 1975–1986 | 1989–1996 | 1997–2007 | 2006–2008 | 2009–2010 | 2016 |
| Number of patients | 84 | 238 | 236 | 48 | 375 | 42 |
| Chagas disease prevalence | 10.7% | 9.6% | 0.4% | 0% | 2.13% | 7.1% |
| Time of screening | Pretransplantation | Pretransplantation | Pretransplantation | Pretransplantation | Posttransplantation | Pre- and posttransplantation |
| Transplanted organs | Kidney | Kidney | Liver | Kidney | Kidney | Kidney, lung and liver |
| Diagnostic test | IHA | IFA, IHA, and ELISA | Serological test (not described) | IFA | ELISA and IFA | ELISA |
ELISA = enzyme-linked immunosorbent assay; IFA = indirect immunofluorescence assay; IHA = indirect hemagglutination.